Advertisement
Screener

AMPHENOL CORPORATION (APH) Scorecard

2.8 / 5 stars · 68/120 Roast Me

AMPHENOL CORPORATION (APH) Scorecard

  • 2026-Q2: Total return Win; Revenue growth Win; EPS growth Win.
  • 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Win.
  • 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
  • 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
71/120 All 120 Win/Lose results shown below

Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.

Trailing 1 year (4 quarters): 11 wins, 1 lossesLast fetched: 4 Sept 2026

Complete point ledger

Each cell identifies the missing side explicitly.

QuarterTotal returnRevenue growthEPS growth
2026-Q23/3 WinAPH / S&P
39.76% / 15.20%
WinAPH / S&P
54.17% / 15.00%
WinAPH / S&P
58.96% / 50.40%
2026-Q12/3 LoseAPH / S&P
-6.32% / -4.33%
WinAPH / S&P
54.40% / 11.30%
WinAPH / S&P
68.93% / 27.70%
2025-Q43/3 WinAPH / S&P
9.41% / 2.65%
WinAPH / S&P
51.71% / 9.00%
WinAPH / S&P
73.96% / 13.40%
2025-Q33/3 WinAPH / S&P
25.49% / 8.12%
WinAPH / S&P
47.37% / 4.61%
WinAPH / S&P
72.41% / 13.45%
2025-Q23/3 WinAPH / S&P
50.82% / 10.94%
WinAPH / S&P
40.51% / 4.83%
WinAPH / S&P
50.30% / 10.63%
2025-Q12/3 LoseAPH / S&P
-5.31% / -4.27%
WinAPH / S&P
30.70% / 4.98%
WinAPH / S&P
26.38% / 10.57%
2024-Q42/3 WinAPH / S&P
6.82% / 2.41%
WinAPH / S&P
21.25% / 5.25%
LoseAPH / S&P
1.05% / 6.15%
2024-Q32/3 LoseAPH / S&P
-3.03% / 5.89%
WinAPH / S&P
14.17% / 5.89%
WinAPH / S&P
123.08% / 6.11%
2024-Q23/3 WinAPH / S&P
17.00% / 4.28%
WinAPH / S&P
6.61% / 5.38%
WinAPH / S&P
42.74% / 5.12%
2024-Q11/3 WinAPH / S&P
16.60% / 10.56%
LoseAPH / S&P
1.52% / 5.71%
LoseAPH / S&P
4.49% / 5.59%
2023-Q42/3 WinAPH / S&P
18.29% / 11.69%
LoseAPH / S&P
-0.54% / 6.81%
WinAPH / S&P
24.18% / 7.78%
2023-Q31/3 WinAPH / S&P
-0.89% / -3.27%
LoseAPH / S&P
0.45% / 7.52%
LoseAPH / S&P
-73.83% / -5.03%
2023-Q20/3 LoseAPH / S&P
4.22% / 8.74%
LoseAPH / S&P
5.26% / 9.50%
LoseAPH / S&P
-59.09% / -8.57%
2023-Q11/3 WinAPH / S&P
7.62% / 7.50%
LoseAPH / S&P
10.43% / 10.77%
LoseAPH / S&P
-42.01% / -15.69%
2022-Q42/3 WinAPH / S&P
14.02% / 7.56%
WinAPH / S&P
16.06% / 11.88%
LoseAPH / S&P
-39.76% / -17.99%
2022-Q33/3 WinAPH / S&P
4.29% / -4.88%
WinAPH / S&P
20.78% / 13.47%
WinAPH / S&P
25.21% / -1.41%
2022-Q23/3 WinAPH / S&P
-14.28% / -16.10%
WinAPH / S&P
22.02% / 13.71%
WinAPH / S&P
26.55% / 11.04%
2022-Q11/3 LoseAPH / S&P
-13.62% / -4.60%
WinAPH / S&P
25.64% / 15.97%
LoseAPH / S&P
28.71% / 42.23%
2021-Q42/3 WinAPH / S&P
19.72% / 11.03%
WinAPH / S&P
26.48% / 15.00%
LoseAPH / S&P
29.59% / 96.40%
2021-Q33/3 WinAPH / S&P
7.25% / 0.58%
WinAPH / S&P
23.45% / 10.77%
WinAPH / S&P
340.74% / 69.42%
2021-Q22/3 LoseAPH / S&P
3.93% / 8.55%
WinAPH / S&P
20.73% / 6.58%
WinAPH / S&P
151.11% / 51.81%
2021-Q12/3 LoseAPH / S&P
1.12% / 6.17%
WinAPH / S&P
12.12% / -1.06%
WinAPH / S&P
48.23% / 7.39%
2020-Q43/3 WinAPH / S&P
21.05% / 12.15%
WinAPH / S&P
4.54% / -3.72%
WinAPH / S&P
4.26% / -33.42%
2020-Q32/3 WinAPH / S&P
13.28% / 8.93%
WinAPH / S&P
0.30% / -2.04%
LoseAPH / S&P
-85.83% / -27.10%
2020-Q21/3 WinAPH / S&P
31.81% / 20.54%
LoseAPH / S&P
-2.72% / -0.46%
LoseAPH / S&P
-76.92% / -27.11%
2020-Q10/3 LoseAPH / S&P
-32.45% / -19.60%
LoseAPH / S&P
-1.99% / 3.47%
LoseAPH / S&P
-63.66% / -14.75%
2019-Q41/3 WinAPH / S&P
12.42% / 9.07%
LoseAPH / S&P
0.29% / 5.36%
LoseAPH / S&P
-51.17% / 2.99%
2019-Q31/3 LoseAPH / S&P
0.85% / 1.70%
LoseAPH / S&P
4.77% / 5.02%
WinAPH / S&P
56.79% / 0.21%
2019-Q22/3 LoseAPH / S&P
1.84% / 4.30%
WinAPH / S&P
9.10% / 6.64%
WinAPH / S&P
69.57% / 8.65%
2019-Q13/3 WinAPH / S&P
16.85% / 13.65%
WinAPH / S&P
13.33% / 8.12%
WinAPH / S&P
77.17% / 14.29%
2018-Q42/3 LoseAPH / S&P
-13.59% / -13.52%
WinAPH / S&P
16.98% / 9.05%
WinAPH / S&P
86.89% / 18.23%
2018-Q31/3 WinAPH / S&P
8.14% / 7.71%
LoseAPH / S&P
APH unavailable / 10.21%
LoseAPH / S&P
-22.61% / 19.06%
2018-Q20/3 LoseAPH / S&P
1.44% / 3.43%
LoseAPH / S&P
APH unavailable / 9.03%
LoseAPH / S&P
-22.56% / 14.46%
2018-Q10/3 LoseAPH / S&P
-1.70% / -0.76%
LoseAPH / S&P
APH unavailable / 7.68%
LoseAPH / S&P
-22.34% / 12.46%
2017-Q40/3 LoseAPH / S&P
3.95% / 6.64%
LoseAPH / S&P
APH unavailable / 7.03%
LoseAPH / S&P
-21.07% / 13.82%
2017-Q32/3 WinAPH / S&P
14.92% / 4.48%
LoseAPH / S&P
APH unavailable / 5.68%
WinAPH / S&P
26.10% / 17.57%
2017-Q22/3 WinAPH / S&P
3.94% / 3.09%
LoseAPH / S&P
APH unavailable / 4.83%
WinAPH / S&P
22.22% / 17.74%
2017-Q12/3 WinAPH / S&P
6.14% / 6.07%
LoseAPH / S&P
APH unavailable / 3.67%
WinAPH / S&P
20.51% / 13.32%
2016-Q41/3 LoseAPH / S&P
3.75% / 3.82%
LoseAPH / S&P
APH unavailable / 2.09%
WinAPH / S&P
8.30% / 7.05%
2016-Q32/3 WinAPH / S&P
13.49% / 3.85%
LoseAPH / S&P
APH unavailable / 0.20%
WinAPH / S&P
4.18% / -3.15%

Dividend-reinvested, split-adjusted total return

1Y · 2025-08-29 to 2026-08-27

MetricAPH total returnS&P 500 Total Return Index
Total return49.26%20.78%
Annualized return49.26%20.78%

5Y · 2021-09-01 to 2026-08-27

MetricAPH total returnS&P 500 Total Return Index
Total return342.32%83.14%
Annualized return34.63%12.86%

10Y · 2016-09-01 to 2026-08-27

MetricAPH total returnS&P 500 Total Return Index
Total return1036.45%319.30%
Annualized return27.51%15.41%

Calculation rules

window
Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
return Basis
Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
point Rule
Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
frequency
Quarter endpoints only.
fundamentals
Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
non Scoring

Snapshot captured 2026-09-04.

Similar stocks

Stock NameCountryMarket CapPE Ratio
METHODE ELECTRONICS INC (MEI)United States$0.519B-13.50
R F INDUSTRIES LTD (RFIL)United States$0.090B54.79